Side-by-side comparison of AI visibility scores, market position, and capabilities
Copenhagen container shipping and integrated logistics (Nasdaq CPH: MAERSK-B) at $55.5B 2024 revenue; +56% net profit to $6.09B from Red Sea disruption with 2025 EBITDA guidance $9-9.5B competing with MSC for global logistics.
A.P. Møller - Mærsk A/S is a Copenhagen, Denmark-based integrated container logistics company — listed on Nasdaq Copenhagen (MAERSK-A, MAERSK-B) — operating as the world's second-largest container shipping company with a fleet serving 374 ports in 116 countries, and an end-to-end logistics provider offering ocean freight, port terminals, land transport, warehousing, air freight, and customs brokerage. In 2024, Maersk reported $55.5 billion in revenue and net profit of $6.09 billion (+56% from 2023), benefiting from Red Sea disruption-driven rate increases (+38.1% container rates) that routed vessels around the Cape of Good Hope, extending voyage times and tightening global capacity. For 2025, Maersk raised its guidance to underlying EBITDA of $9.0-9.5 billion and EBIT of $3.0-3.5 billion. Maersk employs 100,000+ people across 130 countries. Founded 1904 by Arnold Peter Møller and Peter Mærsk Møller; net-zero emissions target by 2040.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.